e-learning
resources
Paris 2018
Wednesday, 19.09.2018
The airway microbiome across the spectrum of airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD
L. Finney (London, United Kingdom), K. Belchamber (London, United Kingdom), P. Fenwick (London, United Kingdom), S. Kemp (London, United Kingdom), S. Johnston (London, United Kingdom), L. Donnelly (London, United Kingdom), J. Wedzicha (London, United Kingdom)
Source:
International Congress 2018 – The airway microbiome across the spectrum of airway disease
Session:
The airway microbiome across the spectrum of airway disease
Session type:
Poster Discussion
Number:
5310
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Finney (London, United Kingdom), K. Belchamber (London, United Kingdom), P. Fenwick (London, United Kingdom), S. Kemp (London, United Kingdom), S. Johnston (London, United Kingdom), L. Donnelly (London, United Kingdom), J. Wedzicha (London, United Kingdom). Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD. 5310
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005
Microbiota educates innate immune response to Toll-like receptors stimulation and RSV infection in lung
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019
The innate immune response to rhinovirus in bronchial epithelial cells is predominately controlled by signalling initiated via MDA-5
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
Cathelicidin modulates the epithelial innate immune response to endotoxin
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Rhinovirus induced innate immune responses in the epithelium of severe COPD
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
Innate immune response of the lung to bacterial and viral stimuli: evidence for a role of epithelial toll-like receptor (TLR) 4 and TLR3
Source: Eur Respir J 2004; 24: Suppl. 48, 210s
Year: 2004
Modulatory effect of atopy on innate immune response to rhinovirus
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
A novel immune regulatory function of neutrophils in rhinovirus infections
Source: Lung Science Conference 2015
Year: 2015
Oral Presentation: Endogenous transforming growth factor influences rhinovirus replication in primary bronchial epithelial cells by suppressing the innate immune response
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011
Infectious Human Rhinovirus persists in in vitro human nasal epithelial cells with waning induction of corresponding innate immune signatures activation
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Inducible epithelial resistance modulates innate antiviral signaling against coronavirus and influenza
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Inflammatory response to infectious pulmonary injury
Source: Eur Respir J 2003; 22: 10S-14S
Year: 2003
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Graphene may modulate the immune activation and survival of monocytes representative of the innate immunity
Source: Annual Congress 2012 - Indoor and outdoor air pollution
Year: 2012
Modulation of the innate and adaptive immune system during coronavirus infection.
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Year: 2021
LSC 2010 Abstract: TLR3 and TLR7 modulate disease course in antigen induced pulmonary inflammation model via influencing humoral immune responses
Source: Annual Congress 2010 - Immune modulation of airways diseases
Year: 2010
The role of innate immune cells in inflammation
Source: International Congress 2015 – Resolving inflammation
Year: 2015
LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept